Top list · Cambridge
Startups in Cambridge
456 startups in Cambridge have raised money in rounds we track. These are the 50 that have raised the most, $19B between them.
- 1
Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.
Founded 2011Cambridge, United States$1.4Blast round Jun 2022 - 2
EQRxEQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.
Founded 2019Cambridge, United States$1.2Blast round Dec 2021 - 3
Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Founded 2016Cambridge, United States$932Mlast round May 2026 - 4
Cambridge Mobile TelematicsCambridge Mobile Telematics (CMT) is the largest telematics service provider globally, founded in 2010 by two MIT professors.Cambridge Mobile Telematics (CMT) is the largest telematics service provider globally, founded in 2010 by two MIT professors.
Founded 2010Cambridge, United States$853Mlast round Mar 2026 - 5
Tango TherapeuticsTango Therapeutics is a biotechnology company that is developing next generation cancer therapies.Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Founded 2017Cambridge, United States$852Mlast round Jun 2026 - 6
Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Founded 2017Cambridge, United States$799Mlast round Dec 2025 - 7
SunoSuno, Inc.Suno, Inc.
Founded 2022Cambridge, United States$750Mlast round Jun 2026 - 8
ModernaLearn how we’re changing the world of medicine.Learn how we’re changing the world of medicine.
Founded 2013Cambridge, United States$675Mlast round Jun 2026 - 9
Flagship PioneeringPioneering Medicines is a biotechnology research agency providing biotechnology to life sciences services.Pioneering Medicines is a biotechnology research agency providing biotechnology to life sciences services.
Founded 2000Cambridge, United States$618Mlast round Dec 2017 - 10
Praxis Precision MedicinesPraxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Founded 2015Cambridge, United States$575Mlast round Jan 2026 - 11
Lila SciencesLila Sciences is a biotechnology company based in Cambridge, Massachusetts, founded in 2023 through a merger of two projects from Flagship Pioneering.Lila Sciences is a biotechnology company based in Cambridge, Massachusetts, founded in 2023 through a merger of two projects from Flagship Pioneering.
Founded -Cambridge, United States$551Mlast round Jan 2026 - 12
Akero TherapeuticsAkero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Founded 2017Cambridge, United States$502Mlast round Mar 2024 - 13
NuvalentNuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Founded 2017Cambridge, United States$500Mlast round Nov 2025 - 14
Intellia TherapeuticsIntellia Therapeutics is a genome editing company that develops curative gene-editing treatments.Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Founded 2014Cambridge, United States$485Mlast round Sept 2026 - 15
LarondeLaronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Founded 2017Cambridge, United States$440Mlast round Aug 2021 - 16
Parabilis MedicinesParabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Founded -Cambridge, United States$380Mlast round Jun 2026 - 17
Editas MedicineEditas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.
Founded 2013Cambridge, United States$335Mlast round May 2026 - 18
Beam TherapeuticsBeam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Founded 2017Cambridge, United States$322Mlast round Feb 2026 - 19
Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Founded 2016Cambridge, United States$310Mlast round Dec 2025 - 20
Rubius TherapeuticsRubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
Founded 2013Cambridge, United States$300Mlast round Mar 2021 - 21
Walden RoboticsWalden Robotics Builds wheeled, two-armed semi-humanoid robots using Physical AI for manufacturing and logistics.Walden Robotics Builds wheeled, two-armed semi-humanoid robots using Physical AI for manufacturing and logistics.
Founded -Cambridge, United States$300Mlast round Jul 2026 - 22
ReNAgade TherapeuticsReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.
Founded 2021Cambridge, United States$300Mlast round May 2023 - 23
Liquid AILiquid AI is a developer of AI applications that help improve human experience.Liquid AI is a developer of AI applications that help improve human experience.
Founded 2023Cambridge, United States$288Mlast round Dec 2024 - 24
Cullinan TherapeuticsCullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Founded -Cambridge, United States$280Mlast round Apr 2024 - 25
Strand TherapeuticsStrand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Founded 2017Cambridge, United States$267Mlast round Mar 2026 - 26
Centessa PharmaceuticalsCentessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Founded 2021Cambridge, United States$250Mlast round Nov 2025 - 27
TriNetXTriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Founded 2013Cambridge, United States$240Mlast round Apr 2026 - 28
LifeMine TherapeuticsLifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Founded 2016Cambridge, United States$230Mlast round Mar 2022 - 29
Iterative HealthIterative Health is a healthcare technology and services company based in Cambridge, Massachusetts, with an additional office in New York City.Iterative Health is a healthcare technology and services company based in Cambridge, Massachusetts, with an additional office in New York City.
Founded 2017Cambridge, United States$227Mlast round Apr 2026 - 30
Orna TherapeuticsOrna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.
Founded 2019Cambridge, United States$221Mlast round Aug 2022 - 31
Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.
Founded 2021Cambridge, United States$220Mlast round Oct 2026 - 32
Obsidian TherapeuticsObsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Founded 2015Cambridge, United States$210Mlast round Apr 2024 - 33
Aviceda TherapeuticsAviceda Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2018.Aviceda Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2018.
Founded 2018Cambridge, United States$208Mlast round Jan 2025 - 34
Voyager TherapeuticsVoyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Founded 2013Cambridge, United States$205Mlast round Jan 2024 - 35
Q32 BioQ32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Founded -Cambridge, United States$200Mlast round Jul 2026 - 36
ITA SoftwareITA Software is an airline IT and services provider helping travel companies reduce costs and improve customer service.ITA Software is an airline IT and services provider helping travel companies reduce costs and improve customer service.
Founded 1996Cambridge, United States$200Mlast round Jan 2006 - 37
Spero TherapeuticsSpero Therapeutics develops therapeutics for treatment of gram-negative infections.Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Founded 2013Cambridge, United States$199Mlast round Jul 2026 - 38
CREATE MedicinesCREATE Medicines is a clinical-stage biotechnology company based in Cambridge, Massachusetts.CREATE Medicines is a clinical-stage biotechnology company based in Cambridge, Massachusetts.
Founded 2019Cambridge, United States$195Mlast round May 2026 - 39
Aera TherapeuticsAera Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.Aera Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.
Founded 2021Cambridge, United States$193Mlast round Feb 2023 - 40
X4 PharmaceuticalsX4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Founded 2012Cambridge, United States$193Mlast round Oct 2025 - 41Infinity PharmaceuticalsInfinity alumni page
Infinity alumni page
Founded 2001Cambridge, United States$181Mlast round Oct 2012 - 42
Generation BioGeneration Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Founded 2016Cambridge, United States$176Mlast round Mar 2023 - 43
Amylyx PharmaceuticalsAmylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Founded 2014Cambridge, United States$175Mlast round Sept 2025 - 44
SuperpedestrianSuperpedestrian is a transportation robotics company located in Cambridge, MA.Superpedestrian is a transportation robotics company located in Cambridge, MA.
Founded 2013Cambridge, United States$168Mlast round Feb 2022 - 45
Scholar RockScholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Founded 2012Cambridge, United States$167Mlast round Mar 2026 - 46
Ethyreal BioEthyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.Ethyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.
Founded -Cambridge, United States$161Mlast round Jun 2026 - 47
Black Diamond TherapeuticsBlack Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Founded 2016Cambridge, United States$160Mlast round Jun 2023 - 48
GentiBioGentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies (EngTregs) to address Type 1 GentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies (EngTregs) to address Type 1
Founded 2020Cambridge, United States$157Mlast round Aug 2021 - 49
AIRNAAIRNA is a biotechnology company founded in 2021, focused on discovering and developing RNA editing therapeutics.AIRNA is a biotechnology company founded in 2021, focused on discovering and developing RNA editing therapeutics.
Founded 2021Cambridge, United States$155Mlast round Apr 2025 - 50
Alkeus PharmaceuticalsAlkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Founded 2011Cambridge, United States$150Mlast round Jun 2023
Cambridge, United StatesEvery startup we hold in Cambridge, ranked by the total it has raised in rounds we hold. Nobody pays to be on a list.
Who backed them?
Open any company for its rounds and investors, or search the investors who back startups in Cambridge in the app, with filters, lists and exports.
More startup lists
See all
O
A
XStartups in the United States42,176 companies · $870B
SCN
FStartups in the United Kingdom8,355 companies · $79BO
D
TMStartups in San Francisco4,251 companies · $350B
W
K
PStartups in New York3,729 companies · $67BF
IL
PDStartups in London3,521 companies · $51B
MAM
TEStartups in France3,025 companies · $32B
C
H8
APStartups in Canada2,950 companies · $38B
BMore lists for Cambridge
See allBMERTBiotech startups in Cambridge183 companies · $16BRTTTKTHealthcare startups in Cambridge85 companies · $9.2BSLSWRAI startups in Cambridge51 companies · $3.4B
T
AT
CIT Services startups in Cambridge33 companies · $244MPMCTMTPharma startups in Cambridge29 companies · $3.0BT
K
TBig Data & Analytics startups in Cambridge23 companies · $688MIST
DLSoftware startups in Cambridge10 companies · $511M